Kaplan-Meier plots based on the risk stratification combining cytogenetics and presence of circulating myeloma cells. (A) OS. (B) TTP. Patients with normal cytogenetics and no circulating myeloma cells have a superior OS and TTP compared with patients with one or both of these parameters.